GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » Cash And Cash Equivalents

Medipal Holdings (TSE:7459) Cash And Cash Equivalents : 円214,659 Mil (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Medipal Holdings Cash And Cash Equivalents?

Medipal Holdings's quarterly cash and cash equivalents increased from Jun. 2023 (円200,182.00 Mil) to Sep. 2023 (円209,053.00 Mil) and increased from Sep. 2023 (円209,053.00 Mil) to Dec. 2023 (円214,659.00 Mil).

Medipal Holdings's annual cash and cash equivalents increased from Mar. 2021 (円222,747.00 Mil) to Mar. 2022 (円243,150.00 Mil) but then declined from Mar. 2022 (円243,150.00 Mil) to Mar. 2023 (円195,031.00 Mil).


Medipal Holdings Cash And Cash Equivalents Historical Data

The historical data trend for Medipal Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings Cash And Cash Equivalents Chart

Medipal Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 213,025.00 207,545.00 222,747.00 243,150.00 195,031.00

Medipal Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 251,958.00 195,031.00 200,182.00 209,053.00 214,659.00

Medipal Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Medipal Holdings  (TSE:7459) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Medipal Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Medipal Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipal Holdings (TSE:7459) Business Description

Traded in Other Exchanges
Address
2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines